Trends in treatment of advanced epithelial ovarian cancer in the Medicare population

Gynecologic Oncology

Volumn 122, Issue 1, 2011, Pages 100-106

  Thrall, Melissa M ^a   Gray, Heidi J ^a   Symons, Rebecca Gaston ^b   Weiss, Noel S ^c   Flum, David R ^a   Goff, Barbara A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Aged; Chemotherapy; Guideline adherence; Ovarian neoplasms; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; CANCER STAGING; CANCER SURGERY; COMORBIDITY; CONFERENCE PAPER; DRUG WITHDRAWAL; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MEDICARE; MULTIPLE CYCLE TREATMENT; OVARY CANCER; PATIENT CARE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DRUG THERAPY; FEMALE; GUIDELINE ADHERENCE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LOGISTIC MODELS; MEDICARE; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; SEER PROGRAM; UNITED STATES;

EID: 79957677519     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.03.022     Document Type: Conference Paper

References (29)

1. Altekruse SF KC, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK, editors. Cancer Facts and Figures - 2010. Institute NC, editor. SEER Cancer Statistics Review 1975-2007; 2010.
2. Altekruse SF KC, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK, editors. SEER Cancer Statistics Review, 1975-2007. Institute NCBethesda, MD; 2010.
3. Choi M, Fuller CD, Thomas Jr CR, Wang SJ. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Gynecol Oncol 2008;109:203-9.
4. NCCN. Practice guidelines in Oncology v.2.2010 Ovarian Fallopian Tube and Primary Peritoneal Carcinomas. In; 2010
5. National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol 1994;55 (3 Pt 2):S4-S14.
6. Goff BA, Matthews BJ, Wynn M, Muntz HG, Lishner DM, Baldwin LM. Ovarian cancer: patterns of surgical care across the United States. Gynecol Oncol 2006;103:383-90. (Pubitemid 44602199)
7. K.M. Fairfield, F.L. Lucas, C.C. Earle, L. Small, E.L. Trimble, J.L. Warren. Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the medicare population. Cancer 2010;116(20):4840-8.
8. van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave AJ, Nardi M, Renard J, Pecorelli S. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995;332:629-34.
9. Weinberg LE, Rodriguez G, Hurteau JA. The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer. J Surg Oncol 2010;101:334-43.
10. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40 IV-3-18.
11. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995;76:2343-50.
12. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83. (Pubitemid 17055592)
14. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care 2002;40 IV-26-35.
15. Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS. Knopf KB. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 2002;40 IV-55-61.
16. Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, Trimble EL, Bodurka DC, Bristow RE, Carney M, Warren JL. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 2006;98:172-80. (Pubitemid 43205479)
17. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group. BMJ 1991;303:884-93.
18. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59. (Pubitemid 34177431)
19. L. Verleye, I. Vergote, A.G. van der Zee. Patterns of care in surgery for ovarian cancer in Europe. Eur J Surg Oncol 2010;36(Suppl 1):S108-14. Epub 2010 Jun 30.
20. Timmermans S, Mauck A. The promises and pitfalls of evidence-based medicine. Health Aff (Millwood) 2005;24:18-28. (Pubitemid 40169771)
21. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65. (Pubitemid 29493800)
22. Chen L, Learman LA, Weinberg V, Powell CB. Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management. Int J Gynecol Cancer 2004;14:1055-62. (Pubitemid 39603347)
23. Chi DS, Eisenhauer EL, Zivanovic O, Sonoda Y, Abu-Rustum NR, Levine DA, Guile MW, Bristow RE, Aghajanian C, Barakat RR. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 2009;114:26-31.
24. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 2006;107:77-85.
25. Bruchim I, Altaras M, Fishman A. Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer. Gynecol Oncol 2002;86:274-8. (Pubitemid 35425522)
26. Chase DM, Rincon A, Deane M, Tewari KS, Brewster WR. Socioeconomic factors may contribute to neoadjuvant chemotherapy use in metastatic epithelial ovarian carcinoma. Gynecol Oncol 2009.
27. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002;40 IV-43-8.
28. Farjah F, Wood DE, Yanez III ND, Vaughan TL, Symons RG, Krishnadasan B, Flum DR. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg 2009;144:14-8.
29. Clark O DB. Forest plots in excel software (Data sheet). In: www.evidencias.com; 2001. p. Web site last accessed 8/2001.